欧盟EMA药品数据库-欧盟集中审批药品（European Medicines Agency Authorisation of Medicines DataBase）

商品名称	适用类别	通用名称	活性成分	产品号	上市许可开发者/申请人/持有人	上市许可日期	许可状态
Rivastigmine 3M Health Care Ltd	Human	rivastigmine	rivastigmine	EMEA/H/C/003824	3M Health Care Limited	2014/04/03	Withdrawn
Rivastigmine Actavis	Human	rivastigmine	rivastigmine hydrogen tartrate	EMEA/H/C/002036	Actavis Group PTC ehf	2011/06/16	Authorised
Rivastigmine 1 A Pharma	Human	rivastigmine	rivastigmine	EMEA/H/C/001181	1 A Pharma GmbH	2009/12/11	Authorised
Rivastigmine Hexal	Human	rivastigmine	rivastigmine	EMEA/H/C/001182	Hexal AG	2009/12/11	Authorised
Rivastigmine Sandoz	Human	rivastigmine	rivastigmine	EMEA/H/C/001183	Sandoz GmbH	2009/12/10	Authorised
Nimvastid	Human	rivastigmine	rivastigmine	EMEA/H/C/001029	Krka, d.d., Novo mesto	2009/05/11	Authorised
Rivastigmine Teva	Human	rivastigmine	rivastigmine	EMEA/H/C/001044	Teva Pharma B.V.	2009/04/17	Withdrawn
Prometax	Human	rivastigmine	rivastigmine	EMEA/H/C/000255	Almirall, S.A.	1998/12/04	Authorised
Exelon	Human	rivastigmine	rivastigmine	EMEA/H/C/000169	Novartis Europharm Limited	1998/05/11	Authorised

商品名称Name of medicine	*示例：Zokinvy（英文）
药品通用名或非专利名称International non-proprietary name (INN) / common name	*示例：lonafarnib（英文）
活性成分Active substance	*示例：lonafarnib（英文）
产品号EMA product number	*示例：EMEA/H/C/005271
ATC编号ATC code	*示例：L01EA06
上市许可开发者/申请人/持有人Marketing authorisation developer / applicant / holder	*示例：Janssen
药物治疗学分组Pharmacotherapeutic group	*示例：Antineoplastic
适应症Therapeutic indication	*示例：leukaemia
许可状态Medicine status
上市许可日期Marketing authorisation date	-